Addex Therapeutics (APE1) Ownership - Who Owns Addex Therapeutics?
Addex Therapeutics (APE1) Ownership Overview
- 67.23% Insiders
- 0.05% Other Institutional Investors
- 32.71% Public Companies and Individual Investors
The ownership structure of Addex Therapeutics (DE:APE1) stock is a mix of institutional, retail, and individual investors. Approximately 0.05% of the company’s stock is owned by Institutional Investors, 67.23% is owned by Insiders, and 32.71% is owned by Public Companies and Individual Investors.
The ownership structure of Addex Therapeutics (DE:APE1) stock is a mix of institutional, retail, and individual investors. Approximately 0.05% of the company’s stock is owned by Institutional Investors, 67.23% is owned by Insiders, and 32.71% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vincent Michael Lawton | 2,507,987 | Insider | 96.57% | 7,461,261 |
| Raymond George Hill | 1,365,532 | Insider | 52.58% | 4,062,458 |
| Roger Mills | 785,976 | Insider | 30.26% | 2,338,279 |
| Mikhail Kalinichev | 306,765 | Insider | 11.81% | 912,626 |
| Jason Raleigh Nunn | 219,561 | Insider | 8.45% | 653,194 |
| Isaac Manke | 219,561 | Insider | 8.45% | 653,194 |
FAQ
Who Owns Addex Therapeutics (DE:APE1)?
According to the latest TipRanks data, approximately 0.05% of the company's stock is held by institutional investors, 67.23% is held by insiders, and 32.71% is held by public companies and individual investors.
What percentage of Addex Therapeutics (DE:APE1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.05% of Addex Therapeutics (DE:APE1) stock is held by institutional investors.
What percentage of Addex Therapeutics (DE:APE1) stock is held by retail investors?
According to the latest TipRanks data, approximately 32.71% of Addex Therapeutics (DE:APE1) stock is held by public companies and individual investors.
Who owns the most shares of Addex Therapeutics (DE:APE1)?
Vincent Michael Lawton owns the most shares of Addex Therapeutics (DE:APE1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
